What do the recent long-term COMMANDS data show?
Dr. Guillermo Garcia-Manero and the panel discuss long-term data from the COMMANDS trial in lower-risk MDS.
66th American Society of Hematology Annual Meeting & Exposition
MDS
Roundtable Discussions
MDS Roundtable
Meetings / Conferences
66th American Society of Hematology Annual Meeting & Exposition
News
Roundtable Discussions
MDS Roundtable
What are second line treatments in lower-risk MDS with anemia?
A roundtable discussion on anemia management in myelodysplastic syndromes, featuring moderator Guillermo Garcia-Manero, MD, of the University of Texas MD Anderson Cancer Center;
Meetings / Conferences
66th American Society of Hematology Annual Meeting & Exposition
Roundtable Discussions
MDS Roundtable
How do you treat patients with MDS and anemia?
A roundtable discussion on anemia management in myelodysplastic syndromes (MDS), featuring moderator Guillermo Garcia-Manero, MD, of the University of Texas MD Anderson Cancer Center;
Meetings / Conferences
66th American Society of Hematology Annual Meeting & Exposition
News
Roundtable Discussions
MDS Roundtable
What novel therapies were discussed at ASH 2024?
A roundtable discussion on anemia management in myelodysplastic syndromes (MDS), Guillermo Garcia-Manero, MD, of the University of Texas MD Anderson Cancer Center; Amy
Leukemia
Lymphoma
Meetings / Conferences
2025 Tandem Meetings
Myelodysplastic Syndromes
News
Hematologic cancer survivors show accelerated brain aging
Dr. Sharafeldin and colleagues examined brain age gap (BAG)—the difference between MRI-derived brain age and chronological age—and white matter hyperintensities (WMH), both markers
News
Society Updates
Save the date: SOHO Israel 2025
Save the date: 3rd SOHO Israel Annual Meeting SOHO Israel has announced that its 3rd SOHO-Israel meeting and 9th International Davidoff conference entitled:
Leukemia
Lymphoma
Multiple Myeloma
Myelodysplastic Syndromes
Myeloproliferative Neoplasms
News
Society Updates
Abstract submissions now open for SOHO 2025
Delegates and attendees are invited to submit an abstract for a poster or oral presentation for the Thirteenth Annual Meeting of the Society
Meetings / Conferences
2025 Tandem Meetings
ACROBAT interim results support AlloHeme for relapse prediction in AML, MDS
Interim results of the ACROBAT study suggest that increasing microchimerism and loss of complete chimerism may indicate relapse risk in patients with acute
Leukemia
Chronic Lymphocytic Leukemia
News
Fixed-duration acalabrutinib-venetoclax combinations outperform SOC in treatment-naïve CLL
Fixed-duration acalabrutinib plus venetoclax with or without obinutuzumab improved progression-free survival over fludarabine-cyclophosphamide-rituximab or bendamustine-rituximab in treatment-naïve chronic lymphocytic leukemia (TN CLL), according
Chronic Lymphocytic Leukemia
Lymphoma
Indolent B-Cell Lymphomas
Multiple Myeloma
Is a stronger flu vaccine better for blood cancer patients?
A correspondence published in The New England Journal of Medicine suggests that a stronger flu vaccine provided little benefit compared with the regular